Alan
Funding History
| Series D · 04/2021 | $1.7B |
|---|---|
| Series E · 05/2022 | $2.9B |
| Series F · 09/2024 | $4.5B |
| 2026 Growth Round · 03/2026 | $5.8B |
About
Alan positions healthcare as a common good to be reinvented rather than a product to sell, and says that controlling its own insurance financing lets it experiment with prevention and care delivery rather than only underwriting risk.
- CEO
- Jean-Charles Samuelian-Werve
- Employees
- 740
- Headquarters
- Paris
- Founded
- 2016
- Website
- alan.com
Overview
Alan is a French health insurance and prevention company, founded in Paris in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin. The company combines statutory-complementary health insurance with a digital prevention and care platform, offering members transparent pricing, automatic reimbursements, and an app-based medical assistant alongside its insurance coverage. Alan sells primarily to employers of all sizes as well as to self-employed workers and retirees, and has expanded beyond France into Belgium, Spain, and Canada, with a growing public-sector business covering French civil servants. Backed by investors including Index Ventures, Coatue, Temasek, and the Ontario Teachers' Pension Plan's Teachers' Venture Growth fund, Alan reached a €5 billion post-money valuation in March 2026 following a €100 million funding round, and reported €785 million in annual recurring revenue for 2025.
Private securities are speculative, illiquid, and involve risk of complete loss of principal. You should be prepared to hold private securities for an extended period; there is no assurance of a secondary market, an IPO, or other liquidity event. You are fully responsible for conducting your own due diligence. Pricing is indicative — nothing here is an offer of securities.